Sweden · Delayed Price · Currency is SEK Midsona AB Earnings Call Transcripts
Fiscal Year 2026
-
Q2 saw improved EBIT and gross margin, with own consumer brands growing 2.3% organically and cash flow strengthening despite contract manufacturing declines. Risenta integration and cost-saving measures supported profitability, while leverage improved to 1.0x.
-
Net sales declined 4.7% year-over-year, but gross and EBIT margins improved due to efficiency and mix. Insurance compensation from the Spanish fire boosted net result, and leverage improved to 0.9x EBITDA.
Fiscal Year 2025
-
Q4 saw organic sales growth of 0.7% and EBIT margin improvement to 5%, driven by strong own brand performance and efficiency gains. Cash flow and leverage reached record levels, while restructuring and product innovation supported profitability.
-
Q3 2025 saw improved EBIT margin and strong growth in own organic brands, despite a sales decline from the Spanish plant fire and currency effects. A restructuring program was launched to accelerate margin gains, and leverage improved to 1.6x.
-
Q2 2025 saw a 2% organic sales decline, with own organic brands returning to growth and private label performing strongly. Gross margin and EBIT fell due to mix and efficiency issues, while a fire in Spain disrupted operations but was quickly contained.
-
Organic net sales grew 1.4% year-over-year, with strong private label and organic category growth, while cash flow and net debt/EBITDA improved. Production ramp-up costs weighed on margins, but stabilization is expected, and a CEO transition is underway.
Fiscal Year 2024
-
Leverage and profitability improved significantly, with net debt/EBITDA at 1.6x and EBIT up 64% year-over-year. Strategic exits from low-margin business boosted gross margin, while focus shifts to organic growth and operational efficiency for 2025.
-
Healthy and sustainable foods remain a strong macro trend, with improved consumer sentiment and operational efficiency driving margin gains. Strategic focus has shifted to portfolio optimization, brand expansion, and innovation, with financial targets set for 2027.
-
Organic sales grew 2.6% year-over-year, with EBIT up 77% and gross margin rising to 28%. Net debt/EBITDA halved to 2.0, reflecting improved financial stability, while ongoing SKU reduction and operational efficiency projects continue to drive margin gains.
-
Q2 2024 saw a return to organic sales growth, margin expansion, and tripled EBIT, with all divisions improving profitability. Key brands performed well, private label and licensed business grew, and leverage improved, though cash flow was impacted by working capital.